At a glance
ClinicalIndex Comparison Record- ✓All children aged 1–60 months (up to but not including the 5th birthday)
- ✓Residing in communities eligible for MORDOR
- ✕Parental or guardian refusal
- ✕Village chief refusal (for village inclusion)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mortality Reduction After Oral Azithromycin Contingency: Mortality Study
In Brief
A Phase 4 clinical trial evaluating Azithromycin and Placebo for Childhood Mortality. Completed, enrolled 66,228 participants across 2 sites in 2 countries.
Detailed Summary
MORDOR was a cluster-randomized placebo controlled trial that assessed the efficacy of mass azithromycin distributions for the prevention of childhood mortality. All communities were subsequently treated with mass azithromycin for one year. The present trial re-randomized communities to azithromycin or placebo for the fourth and fifth year of the study.
Study Details
Timeline
Interventions
Children aged 1 month to 60 months per community will be offered weight or height-based, directly observed, oral azithromycin suspension every 6 months
Children aged 1 month to 60 months per community will be offered weight or height-based, directly observed, oral placebo suspension every 6 months